$SNNA Trying To Fill The Gap?

Huraian

⋅ 1 Okt 2019 pukul 18.31

The clinical-stage biopharmaceutical company (NASDAQ:SNNA) enjoyed an incredible rally and skyrocketed by as much as 76% on Monday.

There was no material news with regards to the company that could have been a catalyst. It is perhaps more intriguing since on September 17 it had emerged that the company had filed for Chapter 11 bankruptcy. This was done in order to restructure the company. That being said, the recent rally makes things very interesting.

Source: 3 Penny Stocks To Buy or Sell In October?

Komen

Nakedsnake14

⋅ 5 Okt 2019 pukul 05.51

lol to be honest when I first looked into the company the first thing I saw was the CH 10 file i also did some background digging ,top down TA, used openinsider for sec filings long story short I bought at .205 put a limit sell at .34 and got some very nice profits EVEN tho i did expect to see some profits that quickly anyways still a good 9 day swing trade

Lebih